University of California San Francisco
Give to UCSF
Transcranial magnetic stimulation (TMS) is a noninvasive in-office procedure. Brief magnetic pulses to the brain induces electrical currents that stimulate nerve cells in specific areas of the brain, providing symptom relief for patients with depression and OCD.
With further validation and clinical trials, the use of artificial intelligence in emergency departments could one day help prioritize patients based on the urgency of their treatment, and help with triage in emergency care.
Life as a former foster youth isn‘t easy, but two students at UC San Francisco have managed to overcome the countless challenges from their experiences.
From left to right: W. Thomas Boyce, MD; Kathleen Giacomini, PhD; Geeta Narlikar, PhD; and Neil Powe, MD, MPH, MBA.Four scientists and clinicians at UC San Francisco have been honored this year with
As the human body ages, cellular changes can drive a host of age-related diseases and conditions. The appearance of aging cells, also called senescent cells, in age-related diseases has spurred the
Kids are more prone to injuries when they do the same sport all year round.
A groundbreaking ceremony launched construction of the $4.3 billion, iconic UCSF Health Helen Diller Hospital at Parnassus Heights.
UCSF scientists have found a set of autoantibodies that emerge in some MS patients years before symptoms.
New CAR-T gene therapy techniques could extend survival for patients with glioblastoma.
When a mouthful of water goes down the wrong pipe – heading toward a healthy person’s lungs instead of their gut – they start coughing uncontrollably. That’s because their upper airway senses the
Mild brain inflammation destroys arm-like projections of neurons rather than the neurons themselves, but can still cause significant brain damage.
UCSF hand surgeon Scott Hansen, MD, offers insight on the importance of plastic surgery in treating hand injuries, especially for those of athletes.
UCSF scientists have been awarded more than $30 million to develop “tissue GPS,” a new system using engineered T cells to guide therapies directly to their targets in the brain to treat neurological diseases like cancer, multiple sclerosis and Alzheimer’s.
